All News

    How Robotic Surgery Can Impact Outcomes For Those With Lung Cancer

    August 1st 2025, 4:00pm

    Article

    CURE spoke with a thoracic surgeon about the impact of minimally invasive surgery for patients.

    Oncolytic Virus Wins FDA Fast Track Designation in Soft Tissue Sarcoma

    August 1st 2025, 2:59pm

    Article

    The U.S. FDA has granted fast track designation to treatment with CLD-201, an oncolytic virus, for patients with soft tissue sarcoma.

    The Significance of the Datroway FDA Approval in EGFR+ NSCLC

    August 1st 2025, 1:00pm

    Video

    Dr. Jacob Sands discusses the significance of the FDA approval of Datroway for the treatment of patients with locally advanced or metastatic EGFR+ NSCLC.

    FDA Grants Orphan Drug Status to SAR446523 for Relapsed Myeloma

    July 31st 2025, 9:00pm

    Article

    SAR446523, an investigational antibody targeting GPRC5D, received FDA orphan drug status and is in phase 1 trials for relapsed/refractory multiple myeloma.

    What is a Neobladder? What Patients with Bladder Cancer Need to Know

    July 31st 2025, 8:00pm

    Video

    Dr. Janet Kukreja explains one urinary diversion option available to patients undergoing bladder removal.

    How Resilience Coaching May Help Young People With Advanced Cancer

    July 31st 2025, 7:00pm

    Article

    A resilience program for young people with advanced cancer helped patients cope early on and led to a better quality of life after 6 to 12 months.

    July GU Cancer Highlights: Top 5 Updates Patients Should Know

    July 31st 2025, 5:00pm

    Article

    As July concludes, new treatments offer advances across kidney and bladder cancer, with breakthroughs in personalized vaccines and non-surgical therapies.

    Can Journaling Help Heal After a Cancer Diagnosis?

    July 31st 2025, 4:00pm

    Article

    Writing helped me focus on gratitude and healing after my colon cancer diagnosis, transforming the act into a powerful recovery tool.

    How GIST Differs From Other GI Cancers

    July 31st 2025, 3:00pm

    Video

    Unlike most GI cancers, GIST starts in supportive stromal tissue, not surface cells, and is classified as a sarcoma, says Dr. Weijing Sun.

    How Can Self-Advocacy Improve Care for Newly Diagnosed Patients?

    July 31st 2025, 1:00pm

    Video

    Six-time cancer survivor Staci Kirk urges patients to trust their bodies and speak up to ensure their needs are understood and addressed throughout cancer care.